Borger et al. discovered the relationship between the expression of EFHD2 and dementia through systematic and comprehensive research, and showed that both protein and mRNA levels of EFHD2 decrease in the frontal cortex of AD and other dementias, such as frontotemporal lobar degeneration. This evidence concerns the gene EFHD2 and frontotemporal dementia.